tiprankstipranks
Trending News
More News >
REPRO-MED Systems (KRMD)
NASDAQ:KRMD
US Market

REPRO-MED Systems (KRMD) Stock Statistics & Valuation Metrics

Compare
290 Followers

Total Valuation

REPRO-MED Systems has a market cap or net worth of $302.02M. The enterprise value is $171.97M.
Market Cap$302.02M
Enterprise Value$171.97M

Share Statistics

REPRO-MED Systems has 46,322,655 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding46,322,655
Owned by Insiders18.02%
Owned by Institutions25.23%

Financial Efficiency

REPRO-MED Systems’s return on equity (ROE) is -0.36 and return on invested capital (ROIC) is -31.00%.
Return on Equity (ROE)-0.36
Return on Assets (ROA)-0.22
Return on Invested Capital (ROIC)-31.00%
Return on Capital Employed (ROCE)-0.32
Revenue Per Employee420.58K
Profits Per Employee-75.83K
Employee Count80
Asset Turnover1.24
Inventory Turnover4.39

Valuation Ratios

The current PE Ratio of REPRO-MED Systems is ―. REPRO-MED Systems’s PEG ratio is 0.51.
PE Ratio
PS Ratio5.24
PB Ratio10.49
Price to Fair Value10.49
Price to FCF-109.04
Price to Operating Cash Flow829.18
PEG Ratio0.51

Income Statement

In the last 12 months, REPRO-MED Systems had revenue of 33.65M and earned -6.07M in profits. Earnings per share was -0.13.
Revenue33.65M
Gross Profit21.33M
Operating Income-6.45M
Pretax Income-6.06M
Net Income-6.07M
EBITDA-5.67M
Earnings Per Share (EPS)-0.13

Cash Flow

In the last 12 months, operating cash flow was 307.26K and capital expenditures -481.17K, giving a free cash flow of -173.91K billion.
Operating Cash Flow307.26K
Free Cash Flow-173.91K
Free Cash Flow per Share>-0.01

Dividends & Yields

REPRO-MED Systems pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.03
52-Week Price Change63.41%
50-Day Moving Average4.80
200-Day Moving Average3.70
Relative Strength Index (RSI)75.74
Average Volume (3m)198.68K

Important Dates

REPRO-MED Systems upcoming earnings date is Mar 4, 2026, After Close (Confirmed).
Last Earnings DateNov 12, 2025
Next Earnings DateMar 4, 2026
Ex-Dividend Date

Financial Position

REPRO-MED Systems as a current ratio of 2.66, with Debt / Equity ratio of 20.28%
Current Ratio2.66
Quick Ratio2.27
Debt to Market Cap<0.01
Net Debt to EBITDA1.01
Interest Coverage Ratio0.00

Taxes

In the past 12 months, REPRO-MED Systems has paid 2.89K in taxes.
Income Tax2.89K
Effective Tax Rate>-0.01

Enterprise Valuation

REPRO-MED Systems EV to EBITDA ratio is -30.72, with an EV/FCF ratio of -105.59.
EV to Sales5.07
EV to EBITDA-30.72
EV to Free Cash Flow-105.59
EV to Operating Cash Flow-534.07

Balance Sheet

REPRO-MED Systems has $8.46M in cash and marketable securities with $3.67M in debt, giving a net cash position of $4.79M billion.
Cash & Marketable Securities$8.46M
Total Debt$3.67M
Net Cash$4.79M
Net Cash Per Share$0.10
Tangible Book Value Per Share$0.35

Margins

Gross margin is 62.32%, with operating margin of -19.16%, and net profit margin of -18.03%.
Gross Margin62.32%
Operating Margin-19.16%
Pretax Margin-18.02%
Net Profit Margin-18.03%
EBITDA Margin-16.52%
EBIT Margin-19.16%

Analyst Forecast

The average price target for REPRO-MED Systems is $6.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$6.25
Price Target Upside-4.14% Downside
Analyst ConsensusStrong Buy
Analyst Count5
Revenue Growth Forecast22.12%
EPS Growth Forecast69.19%

Scores

Smart Score6
AI Score